Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil

Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil

Author Sesso, Ricardo de Castro Cintra Autor UNIFESP Google Scholar
Silva, Camilla Barbosa da Google Scholar
Kowalski, Sergio Candido Autor UNIFESP Google Scholar
Manfredi, Silvia Regina Autor UNIFESP Google Scholar
Canziani, Maria Eugênia Fernandes Autor UNIFESP Google Scholar
Draibe, Sergio Antonio Autor UNIFESP Google Scholar
Elgazzar, Heba A. Google Scholar
Ferraz, Marcos Bosi Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Genzyme Corp
Abstract Objectives: This study evaluates the cost of dialysis care in Brazil, including costs of ambulatory care and hospital admissions due to all causes and cardiovascular events.Methods: Data were analyzed for 200 patients with end-stage renal disease (ESRD) on chronic hemodialysis in Brazil between 2001 and 2004. Main end points were all-cause mortality, all-cause hospital admissions, and cardiovascular events. Direct costs of dialysis treatment and complications were computed from the perspective of two payers, the Ministry of Health (MoH) and private health insurance (PHI).Results: Mean number of days of hospitalization was 12 per patient-year. There were 105 cardiovascular events; the most frequent events were coronary disease (n = 59, 56 percent) and congestive heart failure (n = 26, 25 percent). The rate of cardiovascular events was 193 per 1,000 patient-years. There were 43 deaths, and the death rate was 79 per 1,000 patient-years. Median cost per hospital admission was US$ 675 and US$ 932 from the perspective of the MoH and PHI. For admissions due to cardiovascular causes, the corresponding costs were US$ 1,639 and US$ 4,499, respectively. Mean global cost per patient-year for chronic hemodialysis therapy was US$ 7,980 and US$ 13,428 from the perspective of the MoH and PHI, respectively.Conclusions: Patients on chronic hemodialysis care incur significant healthcare resources due to the costs of dialysis and complications, notably cardiovascular disease. New disease management programs aimed at reducing cardiovascular morbidity and efficient use of resources are critical to ensuring the sustainability of treatments for ESRD in Brazil.
Keywords costs
end-stage renal disease
Language English
Date 2007-12-01
Published in International Journal Of Technology Assessment In Health Care. New York: Cambridge Univ Press, v. 23, n. 1, p. 126-130, 2007.
ISSN 0266-4623 (Sherpa/Romeo, impact factor)
Publisher Cambridge Univ Press
Extent 126-130
Origin https://doi.org/10.1017/S0266462307051665
Access rights Closed access
Type Article
Web of Science ID WOS:000244826100017
URI http://repositorio.unifesp.br/11600/44111

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account